Literature DB >> 18627488

Methotrexate-related leukoencephalopathy without radiation therapy: distribution of brain lesions and pathological heterogeneity on two autopsy cases.

Jun Matsubayashi1, Kuniaki Tsuchiya, Takashi Matsunaga, Kiyoshi Mukai.   

Abstract

This report concerns two rare autopsy cases of methotrexate (MTX)-related leukoencephalopathy without radiation therapy. In the first case, there were widespread necrotic foci with prominent spheroids, that is, disseminated necrotizing leukoencephalopathy (DNL), mainly in the cerebral white matter. In contrast, in the second case, there were widespread demyelinated foci without significant axonal changes, which we would like to name disseminated demyelinating leukoencephalopathy (DDL), mainly in the cerebral white matter. We emphasize that the pathology of pure MTX-related leukoencephalopathy is not uniform, and may show at least two kinds of histologic change. Furthermore, both cases did not develop significant vascular changes, which are usually induced by radiation therapy. The distribution of the lesions in two cases was examined by large specimens, including hemisphere specimens. The distribution of the lesions in the brain of our cases was also different. In the first case, the DNL lesions were predominantly distributed in the frontal and temporal lobes. In the second case, the DDL lesions were prominently localized in the occipital lobe. To our knowledge, this is the first report describing not only the pathological findings of MTX-related leukoencephalopathy without irradiation but also the precise distributions of the lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627488     DOI: 10.1111/j.1440-1789.2008.00945.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  6 in total

1.  Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia.

Authors:  Ji Yeon Kim; Sung Tae Kim; Do-Hyun Nam; Jung-Il Lee; Kwan Park; Doo-Sik Kong
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

2.  Severe, Fatal Methotrexate-related Neurotoxicity in 2 Adolescent Patients With ALL.

Authors:  Sarah Dabagh; Henry David; Sarah Young; Andrew Doan; Deepa Bhojwani
Journal:  J Pediatr Hematol Oncol       Date:  2020-11       Impact factor: 1.170

3.  Disseminated Necrotizing Leukoencephalopathy Complicating Septic Shock in an Immunocompetent Patient.

Authors:  Pedro Gaspar-da-Costa; Sofia Reimão; Sandra Braz; João Meneses Santos; Rui M M Victorino
Journal:  Case Rep Crit Care       Date:  2017-04-24

4.  Toxic leukoencephalopathy with axonal spheroids caused by chemotherapeutic drugs other than methotrexate.

Authors:  Ka Young Lim; Seong-Ik Kim; Hyunhee Kim; Jeongwan Kang; Jin Woo Park; Jae Kyung Won; Dong-Yeop Shin; Sung-Hye Park
Journal:  BMC Neurol       Date:  2022-08-03       Impact factor: 2.903

5.  Population PK/PD model of homocysteine concentrations after high-dose methotrexate treatment in patients with acute lymphoblastic leukemia.

Authors:  Hauke Rühs; Achim Becker; Anne Drescher; John C Panetta; Ching-Hon Pui; Mary V Relling; Ulrich Jaehde
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

6.  Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy.

Authors:  Tommy Sheu; Sarah A Milgrom; Therese Y Andraos; Jillian R Gunther; Linda Chi; Loretta Nastoupil; Nathan Fowler; Yasuhiro Oki; Michelle A Fanale; Luis E Fayad; Fredrick Hagemeister; Sattva S Neelapu; L Jeffrey Medeiros; Chitra Hosing; Yago Nieto; Sairah Ahmed; Amin M Alousi; Bouthaina Dabaja; Chelsea C Pinnix
Journal:  Adv Radiat Oncol       Date:  2018-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.